ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

119 hedge funds and large institutions have $647M invested in Esperion Therapeutics in 2017 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 38 increasing their positions, 31 reducing their positions, and 11 closing their positions.

Holders
119
Holders Change
+20
Holders Change %
+20.2%
% of All Funds
2.97%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.12%
New
37
Increased
38
Reduced
31
Closed
11
Calls
$19.7M
Puts
$66.3M
Net Calls
-$46.6M
Net Calls Change
-$48.9M

Top Buyers

1
BlackRock
1
BlackRock
New York
$45.3M
2
BC
2
Boxer Capital
California
$45M
3
RCM
3
RA Capital Management
Massachusetts
$24.9M
4
PA
4
Pinnacle Associates
New York
$27.2M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$46.2M

Top Sellers

1
AC
1
Aisling Capital
New York
$29.6M
2
DCM
2
Discovery Capital Management
Connecticut
$13.5M
3
BI
3
BVF Inc
California
$0
4
SAM
4
Senzar Asset Management
New York
$0
5
Bank of America
5
Bank of America
North Carolina
$723K
Name Holding Trade Value Shares
Change 		Shares
Change %
USAA
126
United Services Automobile Association
Texas
– -$442K -35,280 Closed
D.E. Shaw & Co
127
D.E. Shaw & Co
New York
– -$310K -24,796 Closed
VRS
128
Virginia Retirement Systems
Virginia
– -$283K -22,600 Closed
AG
129
Advisor Group
Arizona
– -$3K -200 Closed
2 3 4 5
6